Identification of Epigallocatechin-3-Gallate as an Inhibitor of Phosphoglycerate Mutase 1
文献类型：期刊论文
| 作者 | Li, Xiaoguang1,2; Tang, Shuai1; Wang, Qian-Qian3; Leung, Elaine L. -H.3; Jin, Hongyue1; Huang, Yongzhuo1 ; Liu, Jia1; Geng, Meiyu1; Huang, Min1; Yuan, Shengtao2
|
| 刊名 | FRONTIERS IN PHARMACOLOGY
 |
| 出版日期 | 2017-05-30 |
| 卷号 | 8 |
| 关键词 | phosphoglycerate mutase 1 (PGAM1) inhibitor cancer metabolism natural products anticancer activity |
| ISSN号 | 1663-9812 |
| DOI | 10.3389/fphar.2017.00325 |
| 文献子类 | Article |
| 英文摘要 | Targeting metabolic enzymes is believed to provide new therapeutic opportunities for cancer therapy. Phosphoglycerate mutase 1 (PGAM1) is a glycolytic enzyme that importantly coordinates glycolysis, pentose phosphate pathway (PPP) flux and serine biosynthesis in cancer cells and hence gains increasing interest of inhibitor discovery. Only few PGAM1 inhibitors have been reported and the molecular potency remains very limited. In an effort to discover new PGAM1 inhibitors, we carried out a biochemical assay-based screen that was focused on natural products derived small molecule compounds. (-)-Epigallocatechin-3-gallate (EGCG), the major natural catechins of green tea extract, was identified as a PGAM1 inhibitor that was tremendously more potent than known PGAM1 inhibitors. Further studies combining molecular docking and site-specific mutagenesis revealed that EGCG inhibited PGAM1 enzymatic activity in a manner independent of substrate competition. EGCG modulated the intracellular level of 2-phosphoglycerate, impaired glycolysis and PPP and inhibited proliferation of cancer cells. This study suggested EGCG as a chemical scaffold for the discovery of potent PGAM1 inhibitors and gained mechanistic insights to understand the previously appreciated anticancer properties of EGCG. |
| WOS关键词 | GREEN TEA POLYPHENOL ; CANCER-CELLS ; GLUCOSE-METABOLISM ; LUNG-CANCER ; GLYCOLYSIS ; CARCINOMA ; TUMORS ; (-)-EPIGALLOCATECHIN-3-GALLATE ; TELOMERASE ; APOPTOSIS |
| 资助项目 | China International Science and Technology Cooperation Program[2015DFM30040] ; Macao Science and Technology Development Fund[082/2013/A3] ; Macao Science and Technology Development Fund[086/2015/A3] ; Macao Science and Technology Development Fund[005/2014/AMJ] ; National Natural Science Foundation of China[81573464] |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000402269500001 |
| 出版者 | FRONTIERS MEDIA SA |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/272652]  |
| 专题 | 药理学第一研究室 |
| 通讯作者 | Yao, Xiao-Jun; Ding, Jian |
| 作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China; 2.China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing, Jiangsu, Peoples R China; 3.Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Macau, Peoples R China |
| 推荐引用方式 GB/T 7714 | Li, Xiaoguang,Tang, Shuai,Wang, Qian-Qian,et al. Identification of Epigallocatechin-3-Gallate as an Inhibitor of Phosphoglycerate Mutase 1[J]. FRONTIERS IN PHARMACOLOGY,2017,8. |
| APA | Li, Xiaoguang.,Tang, Shuai.,Wang, Qian-Qian.,Leung, Elaine L. -H..,Jin, Hongyue.,...&Ding, Jian.(2017).Identification of Epigallocatechin-3-Gallate as an Inhibitor of Phosphoglycerate Mutase 1.FRONTIERS IN PHARMACOLOGY,8. |
| MLA | Li, Xiaoguang,et al."Identification of Epigallocatechin-3-Gallate as an Inhibitor of Phosphoglycerate Mutase 1".FRONTIERS IN PHARMACOLOGY 8(2017). |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。